Comment: The efficacy of mammography debate is a conflict between the allure of the “early detection saves lives” mantra and the reality that these screenings have never demonstrated a statistically significant improvement in all-cause mortality. The traditional clinical focus on universal mammography ignores the underlying reality that the tradeoff between harms and benefits has been […]
Comment: Although conventional treatments for breast cancer has made astounding improvements over the 35 years that I’ve been in the field, we have to acknowledge that along with it comes a long-term price paid by the patient’s systemic health. This study provides a definitive signal on the iatrogenic risks associated with the standard-of-care. The clinical […]
Comment: The primary disconnect in this data is the dramatic, nearly five-fold reduction in local-regional recurrence that fails to translate into a statistically significant overall survival benefit for the general cohort. While a 10-year local recurrence rate of 11% compared to 22% is a clear victory for regional management, the P=.063 for overall survival reminds […]
Comment: This synthesis serves as a robust rebuttal to the long-standing “precautions” that have dominated lymphedema education. The findings demonstrate that most traditional prohibitions—specifically air travel and blood pressure measurements—are effectively myths that lack Level 1 or 2 evidence. The core tension is between a historical focus with these external triggers and the clinical reality […]
Comment: This study provides the critical ‘why’ behind the findings from this same groups earlier study. In that article, we highlighted that exogenous thyroid hormone is associated with significantly shortened survival in SR+ breast cancer patients. Now, this research explains elucidates the underlying mechanism: thyroid hormone essentially ‘hijacks’ the estrogen receptor, driving proliferation and rendering […]
Comment: This paper serves as a major wake-up call regarding the risks of thyroid replacement in SR+ breast cancer, which compromises about 80% of cases. The mechanistic finding—that thyroid hormone can reverse Tamoxifen’s action from antagonist to agonist—is a critical piece of the puzzle explaining treatment failure. Furthermore, the observation that Aromatase Inhibitors also showed […]
Comment: Cancer survivors are still frequently told that they should avoid antioxidants due to the wholly theoretical risk that they might ‘rescue’ residual cancer cells. This large-scale analysis effectively dismantles that dogma. Instead of harm, we see a clear survival advantage—a 16% reduction in total mortality for those using antioxidants post-treatment. Whether it is the […]
Comment: While the headline of this study suggests a clear danger, the methodology reveals significant issues which makes the results difficult to trust. They ‘lump’ biologically distinct agents—grouping trace minerals like selenium with high-dose Vitamin C—which renders the ‘antioxidant’ variable clinically meaningless. This is the same mistake done in this trial, which is really a […]
Comment: This study is not the only one showing NSAIDs (vs tylenol) for pain management around surgery has a potential upside. However what this ones suggests is that ketorolac specifically may be a better option than other NSAIDS. that a standard perioperative analgesic acts as a potent anti-cancer agent by ‘abrogating’ the specific inflammatory signal […]
Comment: While this data from the ‘donna’ program shows a statistically significant survival advantage for screened patients, we can’t conflate ‘survival’ with ‘reduced mortality.’ The study design focuses on women already diagnosed with breast cancer, which inherently makes the results susceptible to lead-time bias—where earlier detection creates an illusion of longer survival without necessarily changing […]
